Approved Medicines vs Research Peptides

How we label evidence

We use plain labels: approved medicine (regulator and use named), established, promising but limited, mixed, insufficient evidence, preclinical (cells or animals only), no good evidence of benefit, evidence of harm, and marketing claim.

What approval means

The U.S. FDA says its approval means data on the drug's effects were reviewed and the benefits were judged to outweigh the known and potential risks for the intended population. [1] Before a drug is tested in people, laboratory and animal tests are done, then tests in people check safety and real benefit. [1] Generally the agency expects two well-designed trials, though one convincing trial can be enough in some cases, such as rare disease. [1] Approval is for an intended use, with a label that lists indications and major risks. For example, the tesamorelin label lists one use, reducing excess abdominal fat in HIV-infected adults with lipodystrophy. [2] Evidence label: approved medicine, U.S. FDA, for that use only.

What "research peptide" usually means

There is no regulatory category called "research peptide." The phrase is used for compounds sold or promoted outside the approval system. The FDA states that unapproved versions of drugs do not undergo its review for safety, effectiveness and quality before marketing. [3] Many appear on the FDA's list of bulk substances with possible significant safety risks for compounding; this is a safety notice and not an approval or a formal ban. [4] See approved, investigational and unapproved peptides and research use only labels.

A worked example: BPC-157

A 2025 systematic review of BPC-157 in orthopaedic sports medicine, searching to June 2024, included 36 studies. Of these, 35 were preclinical and 1 was a clinical study. [5] In animal models, outcomes improved in muscle, tendon, ligament and bone injury. [5] The one clinical study was retrospective: 7 of 12 patients with chronic knee pain reported relief for more than 6 months after an injection into the joint. [5] The review found no clinical safety data. [5] The FDA separately says it lacks sufficient information to know whether the drug would cause harm in humans. [4]

Evidence label: preclinical, plus insufficient evidence in people. Animal results cannot be carried over into human recovery claims. Details are on the BPC-157 page.

The difference at a glance

Claim check: "It is backed by research"

• What the claim says: studies exist, so the product is proven.
• What evidence exists: for many such compounds, mostly cell and animal studies. [5]
• Where it stops: animal healing does not show human benefit, and a study of a lab-made compound is not a study of a vial sold online. See how to evaluate peptide claims.

No universal winner

This is not a contest. Approved medicines have known uses and known risks. Research peptides have unknowns. People considering either can discuss it with a prescriber.